Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Amid GLP-1 Pricing Uncertainty

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Amid GLP-1 Pricing Uncertainty

Nektar Therapeutics (NKTR) Strength Attributed to Rumor

October 17, 2025 1:32 PM EDT

Nektar Therapeutics (NASDAQ: NKTR) Strength Attributed to Rumor

Shares are up over 13pct today.Afternoon spikes attributed to Betaville post, which traders are circulating, noting Eli Lilly & Co. (NYSE: LLY) "could possibly" seek an... More